Literature DB >> 1695828

New glucocorticoids. Mechanisms of immunological activity at the cellular level and in the clinical setting.

M Scudeletti1, L Castagnetta, B Imbimbo, F Puppo, I Pierri, F Indiveri.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 1695828     DOI： 10.1111/j.1749-6632.1990.tb34310.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  11 in total

1.  Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients.

Authors:  Jorge R Ferraris; Titania Pasqualini; Guillermo Alonso; Susana Legal; Patricia Sorroche; Ana M Galich; Héctor Jasper
Journal:  Pediatr Nephrol       Date:  2007-02-09       Impact factor: 3.714

2.  Gender-related assessment of cyclosporine/prednisolone/sirolimus interactions in three human lymphocyte proliferation assays.

Authors:  G M Ferron; N A Pyszczynski; W J Jusko
Journal:  Transplantation       Date:  1998-05-15       Impact factor: 4.939

3.  Pharmacokinetic and pharmacoimmunodynamic interactions between prednisolone and sirolimus in adrenalectomized rats.

Authors:  G M Ferron; N A Pyszczynski; W J Jusko
Journal:  J Pharmacokinet Biopharm       Date:  1999-02

4.  Deflazacort in the treatment of haematologic disorders.

Authors:  M Gobbi; M Scudeletti
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

5.  Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation.

Authors:  Mindy He Magee; Robert A Blum; Christian D Lates; William J Jusko
Journal:  Br J Clin Pharmacol       Date:  2002-05       Impact factor: 4.335

6.  Interferons up-regulate with different potency HLA class I antigen expression in M14 human melanoma cell line. Possible interaction with glucocorticoid hormones.

Authors:  L Lanza; L Peirano; O Bosco; P Contini; G Filaci; M Setti; F Puppo; F Indiveri; M Scudeletti
Journal:  Cancer Immunol Immunother       Date:  1995-07       Impact factor: 6.968

Review 7.  Deflazacort. A review of its pharmacological properties and therapeutic efficacy.

Authors:  A Markham; H M Bryson
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

8.  Comparison of two glucocorticoid preparations (deflazacort and prednisone) in the treatment of immune-mediated diseases.

Authors:  M Scudeletti; F Puppo; L Lanza; L Mantovani; O Bosco; A Iudice; B Imbimbo; F Indiveri
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes.

Authors:  L Lanza; M Scudeletti; F Puppo; O Bosco; L Peirano; G Filaci; E Fecarotta; G Vidali; F Indiveri
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

Review 10.  Prevention and treatment of severe hemodynamic compromise in pediatric heart transplant patients.

Authors:  John M Costello; Elfriede Pahl
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.